Pivotal RELIVE Trial Is Evaluating the Safety and Efficacy of BioVentrix’s Revivent System in the Treatment of Patients Who Have Experienced Heart Failure
Seasoned Executive Brings Strategic Insight and Financial Expertise to Support Company’s Governance and Funding Initiatives.
Renowned cardiovascular experts bring decades of clinical, research, and leadership [...]
Renowned Physicians in the Field of Cardiology to Lead [...]
Brings Extensive Leadership Experience to Senior Management TeamMansfield, MA – [...]
Revolutionary Heart Failure Therapy Company Also Adds New Executive and [...]
SAN RAMON, Calif. – July 21, 2021 – BioVentrix, Inc., [...]
Proven Leader Will Take Revolutionary Heart Failure Therapy Company to [...]
San Ramon, Kalifornien, und Hilden bei Düsseldorf, 19. Februar 2021„Bringing [...]
SAN RAMON, Calif. – February 8, 2021 - BioVentrix, Inc., [...]
BioVentrix is a privately held medical device company headquartered in Mansfield, MA USA.
MKT-0028, Rev. BC
DCO# 4612
02/12/2026
© 2026 BioVentrix, Inc. All Rights Reserved. Powered by eLearnza
BioVentrix and the Heart Logo are trademarks or registered trademarks of BioVentrix, Inc. Any unauthorized use is expressly prohibited.
Investigational Device. The Revivent System is limited to Investigational Use Only In The United States.
